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ABSTRACT
The ability to engineer genetic programs governing
cell fate will permit new safeguards for engineered
organisms and will further the biological under-
standing of differentiation and aging. Here, we
have designed, built and implemented a genetic
device in the budding yeast Saccharomyces
cerevisiae that controls cell-cycle progression
selectively in daughter cells. The synthetic device
was built in a modular fashion by combining timing
elements that are coupled to the cell cycle,
i.e. cell-cycle specific promoters and protein degra-
dation domains, and an enzymatic domain which
conditionally confers cell arrest. Thus, in the
presence of a drug, the device is designed to
arrest growth of only newly-divided daughter cells
in the population. Indeed, while the engineered cells
grow normally in the absence of drug, with the drug
the engineered cells display reduced, linear growth
on the population level. Fluorescence microscopy of
single cells shows that the device induces cell arrest
exclusively in daughter cells and radically shifts the
age distribution of the resulting population towards
older cells. This device, termed the ‘daughter
arrester’, provides a blueprint for more advanced
devices that mimic developmental processes by
having control over cell growth and death.
INTRODUCTION
Control over cell fate is a biological process ubiquitous in
nature. In unicellular organisms it is used to control cell
division and in multi-cellular organisms it regulates
developmental processes. External control of cell fate
has been demonstrated using a variety of chemical,
genetic and small molecule methods. Small molecules
that perturb signaling pathways of stem cells are used to
modulate cell fate decisions (1,2) such as diﬀerentiation,
cell survival and proliferation (3). Alternatively, suicide
gene therapy is used to selectively kill cells that have
taken up an exogeneous gene, which converts a prodrug
to an active drug (4). In bacteria, a more complex genetic
feedback circuit based on quorum sensing similarly con-
trols cell fate to enable programmed population control
(5,6). However, the described systems above act condition-
ally depending on population density and/or aﬀect
all genetically identical cells, rather than exerting selective
control over certain members of a genetically identical
population at a speciﬁc cell cycle or developmental
stage. The ability to read the cell-cycle state and
act upon it could allow for more ﬁne-tuned devices that
implement conditional programs or tightly time-regulated
behaviors.
Cells undergo highly regulated transcriptional, trans-
lational and degradation programs to progress through
the cell-cycle, and these programs are regulated by
modular elements (7,8). We reasoned that we could use
rational design of modular elements to design a genetic
device to selectively arrest newly formed cells upon a con-
ditional signal in a cell density independent fashion.
Living systems are, in principle, organized from building
blocks that through their interactions give rise to their
inherent complexity. Modularity in nature has led to the
idea of re-using genetic parts to form a synthetic biology
toolbox comprising diﬀerent functions that can be
interfaced and recombined (9). This toolbox encom-
passes genetic components such as promoters, functional
protein domains, operator regions as well as non-coding
regulatory regions such as miRNAs. Parts can then be
pieced together to generate circuits encoding commands
or tasks that can be carried out in series or in parallel.
For example, Chen et al. (10) integrated exogenous syn-
thesis and receptor modules from Arabidopsis thaliana
into Saccharomyces cerevisiae’s endogenous protein
phosphorylation pathway to implement artiﬁcial cell-cell
communication in yeast. Also using a modular approach,
Ajo-Franklin et al. (11) built a positive feedback
loop by assembling novel proteins based on modular
protein domains to achieve new functionality. Other
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elsewhere (9,12–15). Despite this explosion of genetic
devices, the integration of engineered genetic circuits
into native cell-cycle progression remains an
unexplored area.
Here we report construction of a ‘daughter arrester’, a
device that arrests the growth of daughters while allowing
mother cells to grow. To accomplish this, we engineered a
drug-sensitive enzyme that is transiently present in yeast
daughters during the normal cell-cycle progression. In the
absence of the drug, all cells divide normally (Figure 1A),
while in the presence of the drug, the enzyme selectively
arrests daughter cell growth (Figure 1B). This device con-
stitutes a ﬁrst successful attempt in building a modular
genetic device that integrates information from the
endogenous cell-cycle and an external stimulus. Devices
that follow this design philosophy have potential applica-
tion as tools to study aging and as fail-safe devices that are
activated based on proliferation rates.
MATERIALS AND METHODS
Yeast strains
The constructs used to create the early (PSY3651) and late
(PSY3652) daughter arrester strains were assembled in
sequential fashion using the Biobrick assembly method
(16). All promoters or proteins sequences are from
S. cerevisiae unless otherwise noted and were subcloned
from PSY580 genomic DNA. The CTS1 and DSE4 pro-
moters were subcloned from region  762 to  3 and from
region  1233 to  3, respectively, relative to the start
codon of their downstream coding sequence. Both pro-
moters were fused to a Kozak sequence containing
the start codon, and the coding sequences of the G1/S
degradation tag (amino acids 2–160 of Sic1p), PKI
nuclear export sequence (NES; amino acid sequence
ELALKLAGLDIN), Ura3p (amino acids 2–267), yeast
codon optimized Venus yellow ﬂuorescent protein
(17,18) and the SV40 NLS (amino acid sequence
no drug drug added
Budded cells arrest 
after adding the drug
AB
YFP NLS NES G1/S deg tag conditional 
killer gene
daughter specific 
promoter
C
early promoter: DSE4 
late promoter: CTS1 
pCTS1
pDSE4
Birth
5-FOA
5-FU
G1 G1/S
5-FU
5-FU
5-FU
S/G2/M
5-FU
5-FU
5-FU
5-FU
D
Figure 1. Design of the daughter arrester. (A) Mother and daughter yeast cells of the daughter arrester strain both divide normally in the absence of
drug. In the presence of drug (B), mother cells continue to undergo cell divisions, but daughter cells arrest (red) and fail to divide. (C) The daughter
arrester is a gene comprised of a daughter speciﬁc promoter (pCTS1 or pDSE4 for the early or late daughter-speciﬁc arrester, respectively), a G1/S
degradation tag (the N-terminal of Sic1p) fused to the PKI nuclear export sequence (NES), the conditional killer protein (Ura3p), the Venus yellow
ﬂuorescent protein (YFP), and the SV40 nuclear localization sequence (NLS). (D) Detail of the engineered strain throughout the cell cycle. The
ﬂuorescent conditional kill protein (yellow ovals) is expressed due to daughter speciﬁc promoters at birth (panel 1), shuttles between the nucleus and
cytoplasm, and converts the pro-drug (5-FOA) to the toxic 5-FU throughout G1 (panel 2). At the G1/S transition (panel 3), this protein is targeted
for proteasomal degradation due to the degradation tag (C, in red). As the cell progresses through the cell cycle (panel 4), the daughter cell will arrest
due to the incorporation of 5-FU in RNA and DNA.
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ﬁnal Biobrick constructs were conﬁrmed by sequencing
and then subcloned into pRS integrating vectors (19).
The pRS vectors were then linearized and integrated
into the URA3 mutant PSY580 strain (MATa, ura3-52,
trp163, leu21) at the TRP1 locus. Integrations were
conﬁrmed by colony PCR.
Spectroscopy
Yeast cultures were grown overnight in synthetic complete
media, back diluted to an OD600 0.2, grown until OD600 of
0.6, and back diluted again to OD600 0.2. Two milliliters of
culture were then transferred to two plastic cuvettes
containing magnetic stir bars. The drug 5-ﬂuoroorotic
acid (5-FOA) (100mg/ml in DMSO) (Sigma Aldrich,
St. Louis, MO) was added to a ﬁnal concentration of
1mg/ml to one of the cultures, an equal volume of
DMSO was added to the second, and the OD600 of both
cultures was measured every 5min for 7h at a constant
30 C with stirring using a Cary 300 spectrophotometer.
Growth assays
Yeast cultures were grown overnight in synthetic complete
media, back diluted to an OD600 0.2, grown until OD600 of
0.6, and back diluted again to OD600 0.2. These cultures
were serially diluted by factors of 10 and spotted from the
leftmost side to the right on plates containing diﬀerent
types of media.
Cell imaging
Time-lapse movies of yeast growth were obtained
by seeding and growing cells within a microﬂuidic
device (CellASIC Corporation, Berkeley, CA) according
to the manufacturer’s instructions. Time-lapse microscopy
acquisition was obtained using Metamorph software using
a Nikon TE-2000 inverted microscope with automated
stage inside a temperature controlled chamber set to
30 C. The JP2 ﬁlter set from Chroma was used for YFP
acquisition every 3min. Image analysis was performed
using Metamorph and NIH ImageJ software (20).
RESULTS
Design of daughter arrester
Our goal was to design a gene that would selectively
prevent daughter cells from dividing. Thus the protein
product of this gene needed to meet design speciﬁcations:
it would (i) arrest cell growth if and only if the drug were
present (otherwise the strain could never propagate),
(ii) be expressed only in daughter cells after cytokinesis,
but be degraded before the daughter cell completed its ﬁrst
cell division, (iii) be in the appropriate cellular compart-
ments to carry out the above functions, and (iv) be readily
detectable. To meet these criteria, we combined genetic
modules for a conditionally lethal enzyme with cell-cycle
dependent synthesis, cell-cycle dependent degradation,
visualization and subcellular localization (Figure 1C) as
described in detail below.
Our ﬁrst major consideration was to use a gene
encoding an enzyme capable of interacting with certain
substrates, generating a toxic chemical and inducing cell
death—we term this the ‘conditional killer gene’. We
selected URA3 as the conditional killer gene; it codes for
the protein orotidine-50-phosphate (OMP) decarboxylase
which converts 5-FOA into the cytotoxic pyramidine
analog 5-ﬂuorouracil (5-FU) (21). 5-FU misincorporates
into RNA and DNA in place of uracil or thymine, ham-
pering normal RNA and DNA processing, and leads to
cell arrest (22). In strains lacking the URA3 gene, 5-FOA
is not converted into 5-FU, and cell growth is not aﬀected
(23).
The second key design requirement was to restrict this
conditional killer protein to daughter cells. Therefore, we
paired a cell-cycle dependent promoter with a cell-cycle
dependent protein degradation sequence to limit this
protein to daughter cells between G1- and S-phase.
To prevent the conditional kill protein from being
present past G1 (24,25), we fused the N-terminal region
of Sic1p in frame to the conditional kill gene coding
sequence. This protein region, a so-called G1/S degrada-
tion tag, causes protein fusions (26) to be speciﬁcally
degraded at the G1/S transition with the same timing as
the native Sic1p (27). Since our engineered protein must be
present long enough to convert 5-FOA into 5-FU, yet
should not be present before G1, we chose two diﬀerent
promoters with slight diﬀerent temporal patterns of
expression to create two versions of our device. While
both the CTS1 and DSE4 promoters (28,29) speciﬁcally
drive gene expression in newly budded cells, CTS1 lags
slightly behind DSE4 in driving the expression of any
gene coupled to it (29). Hence we term the DSE4
promoter-variant of our device the ‘early daughter
arrester’ and the CTS1-variant the ‘late daughter arrester’.
Lastly, we included genetic modules for subcellular
localization and visualization in our device. Since OMP
decarboxylase is usually a cytosolic protein, yet RNA and
DNA processing occur in the nucleus, we reasoned that we
could increase the probability of arrest by targeting our
fusion protein to both compartments. A partial nuclear
localization is also necessitated by our G1/S degradation
tag: the degradation of endogenous Sic1 is triggered in the
nucleus, where it is phosphorylated by B-type cyclins (27).
Thus, the coding sequence for both a nuclear localization
signal (NLS) and a nuclear export signal (NES) were fused
to the URA3 module. A protein that contains both signals
continuously shuttles (30) between the cytoplasm and the
nucleus. As a ﬁnal component, a yeast codon optimized
YFP DNA sequence was fused to the Sic1 module in order
to quantify the presence of the engineered protein with
spatial and temporal resolution.
Assuming these components maintain their modularity,
we can build a timeline predicting how our device should
selectively arrest daughter cells (Figure 1D). Starting at
birth (panel 1), the daughter-speciﬁc promoters are
up-regulated and result in expression of the ﬂuorescent
conditional kill protein (yellow ovals). Throughout G1
(panel 2), this protein will continue to be expressed, will
shuttle continuously between the cytoplasm and the
nucleus, and will convert 5-FOA (if present) into 5-FU.
Nucleic Acids Research,2010, Vol.38, No. 8 2729At the G1/S transition (panel 3), the daughter-speciﬁc pro-
moters will no longer be active and the conditional kill
protein will be phosphorylated in the nucleus,
ubiquitinated, and rapidly degraded by the proteasome.
Subsequently (panel 4), the daughter cell will arrest due
to incorporation of 5-FU in RNA and DNA. In contrast,
mother cells should not express the conditional kill protein
and should divide normally.
The daughter arrester conditionally inhibits growth
of bulk cultures
To test whether this genetic device could conditionally
arrest cell growth on the population level, the wild-type,
early daughter arrester and late daughter arrester strains
were grown in liquid culture, serially diluted starting from
the same initial cell density, and plated on rich media and
synthetic complete plates with and without the added drug
5-FOA (Figure 2A–C). All three strains cells grew to a
similar extent when grown on rich YEPD (Figure 2A) or
synthetic complete media (Figure 2B), suggesting that the
device does not aﬀect growth in the absence of a drug.
Likewise, cell growth of the wild-type strain in the
presence of drug was not aﬀected (Figure 2C), indicating
that the drug does not impact its growth. In comparison,
both the early and late daughter arrester strains displayed
reduced growth, as demonstrated by the growth of fewer
colonies in the serial dilution (Figure 2C). Additionally,
the early daughter arrester strain displayed a slower
growth rate compared to late daughter arrester strain.
Based on these results, we used only the early daughter
arrester strain in the subsequent experiments.
Under normal growth conditions, the biomass and cell
density of a yeast cell culture grow exponentially over time
after the lag-phase and before stationary-phase. In a pop-
ulation where the newly budded cells arrest their transit
through the cell cycle, biomass will be generated in a linear
fashion since current mother cells will bud new cells, but
these new cells will fail to bud (Figure 1B). The plot of cell
growth versus time can be qualitatively described by one
of the following behaviors: (i) concave up, typical of
a wild-type population during exponential growth; (ii) con-
cave down, expected for a growing population where
mother and daughter cells arrest or die and cease to
bud; (iii) linear, expected for a growing population
where mother cells continuously bud new daughter cells
that get arrested. In order to assay growth rate over time
we indirectly quantiﬁed biomass by measuring light scat-
tering at 600nm using a spectrophotometer.
Measurements were obtained while growing yeast cell
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Figure 2. The daughter arrester strain shows reduced growth on the population level only in the presence of drug. Serial dilutions of the parent
strain (PSY580), the early daughter arrester (pCTS1, PSY3652) and the late daughter arrester strain (pDSE4, PSY3651) on (A) rich media (YEPD),
(B) synthetic complete media (SC) and (C) synthetic complete media containing the drug 5-FOA show that only in the presence of drug, cell growth
of the daughter arrester strains is reduced. (D) Biomass growth as measured by OD600 as a function of time for the early daughter arrester strain in
the absence (circles) and presence of drug (squares) indicates that normal exponential growth is observed without drug while the predicted linear
growth is observed in the presence of drug.
2730 Nucleic Acids Research, 2010,Vol.38, No. 8cultures in a temperature controlled well-stirred mini-
reactor. Figure 2D shows a representative time course
of the early daughter arrester strain growing in the
mini-reactor over time in the presence and absence of
the stimulus. Cells grown in the absence of drug (circles)
display exponential growth similar to wild-type cells (data
not shown), whereas cells grown in the presence of drug
(squares) display reduced growth that ﬁts perfectly to
a linear regression [OD600=0.215+0.123 time (h),
R
2=1.00]. These observations indicate that engineered
genetic device reduces the rate of cell division in a
manner that is qualitatively consistent with our design.
The daughter arrester conditionally inhibits growth of
daughter cells
In order to determine whether the reduced growth of the
populations expressing our genetic device was due to the
arrest of the newly budded daughter cells, we followed
individual cells in a microﬂuidic device by diﬀerential
interference contrast and ﬂuorescence microscopy.
The microﬂuidic format conferred two important advan-
tages: the media composition could be changed within less
than 1min without altering the ﬁeld of view and growing
cells remained in the same focal plane because they are
trapped in a 4mm high region. In a typical experiment, the
microﬂuidic chamber was seeded with cells, the cells were
grown for 1h in synthetic complete media, and then the
media was switched to either drug-containing media (t=0
in Figure 3), and individual cells were tracked over many
generations.
We analyzed representative cell trajectories for the early
daughter arrester strain grown in the presence and absence
of drug (Figure 3). Figure 3A shows a mother cell
(outlined in yellow), its ﬁrst, second and third daughter
cells (outlined in red, green and blue, respectively) and
their progeny (outlined in red, green and blue) when
grown in the absence of drug. While the mother cell
divides several times over the course of the experiment,
it never shows signiﬁcant ﬂuorescence. In contrast,
newly budded cells (e.g. ﬁrst daughter cell outlined in
red) rapidly accumulate bright ﬂuorescence centered in
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Figure 3. Time-lapse microscopy and single-cell analysis of daughter arrester cells growing in a microﬂuidic device shows speciﬁc arrest of daughter
cells only in the presence of drug. Cells were seeded into a microﬂuidic device and grown in the absence of drug for 1h before switching to either
identical or drug-containing media. (A) When grown in the absence of drug, newly budded cells (outlined in red, green and blue) are ﬂuorescent
from G1- to S-phase, and both mothers (outlined in yellow) and daughters progress through the cell cycle. When grown in the presence of drug
(B), a mother cell (outlined in yellow) divides multiple times, but its daughter cells (outlined in red, green and blue) do not complete a cell division.
(C) Average ﬂuorescence intensity of single cells shown in (B) as a function of time. The peaks of ﬂuorescence intensity have remarkably similar
durations as well as magnitudes.
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cell enters into S-phase and then it rapidly disappears and
does not reappear (Figure 3A, panels 2–6). This pattern of
expression and degradation indicates that the CTS1
daughter-speciﬁc promoter and G1/S degradation tag
can be combined in a modular fashion to tightly restrict
an arbitrary protein to a particular phase of the cell cycle.
The predominately nuclear localization of the conditional
killer protein is in accordance with previous observations
in human ﬁbroblasts that a fusion protein carrying both
the PKI NES and the SV40 NLS leads to predominately
nuclear localization (31), indicating that in this conﬁgura-
tion the NLS prevails. Additionally, both mother and
daughter cells of the daughter arrester strain divided
many times over the course of the experiment and dis-
played a growth rate inside the microﬂuidic device com-
parable to their wild-type counterparts ( 90min).
When grown in the presence of the drug, both mother
cells and post-G1 daughter cells of the daughter arrester
strain are not signiﬁcantly ﬂuorescent (Figure 3B) and
divide at slightly slower rate compared to wild-type cells
in the absence of drug (140 versus 90min, respectively).
We speculate that this slower growth could be due to very
low expression of conditional killer protein or a bystander
eﬀect originating from nearby arrested daughter cells.
As in the absence of drug, ﬂuorescence appeared only in
newly budded cells, e.g. red cell in panel 2, and then
precipitously disappeared as the cells entered into
S-phase. However, these cells subsequently arrested as
they started to bud new cells, e.g. red cell in panels 3–6,
and never completed a cell division over the next  14h,
i.e. until the end of the experiment.
In order to quantitatively assess the function of our
daughter arrester strain on the population level and to
identify possible modes of failure, we analyzed the
trajectories of many cells grown and imaged under identi-
cal conditions as Figure 3B. Of the daughter cells born in
the presence of drug (n=185), 86% arrested after the
G1/S transition and did not complete a cell division
during the remainder of the experiment (>30min).
Additionally, a very small subset of the daughter cells
died before the G1/S transition. Interestingly, the
daughter cells that completed a division displayed notice-
ably slower growth and in all cases that we observed, their
daughters do arrest. Thus we suggest that these cells have
divided in spite of signiﬁcant accumulated damage rather
than mutating in such a way that 5-FOA is no longer
converted into toxic 5-FU.
Quantifying the average ﬂuorescence intensity of the
YFP reporter, which is indicative of the protein concen-
tration, allows a ﬁne-grained examination of device
function over multiple cell divisions (Figure 3C). The ﬂu-
orescence intensity as a function of time for a mother cell
and three of its daughter cells is plotted in Figure 3B and
C, in where mother cell is circled in yellow and daughter
cells are indicated by red, green, and blue outlines,
respectively. The mother cell only displays a very small
ﬂuorescent signal above its own time averaged back-
ground level some minutes before the newly budded cell
shows a ﬂuorescent signal. Newly budded cells display a
ﬂuorescent signal with a remarkable features that are
reproduced over several generations (Figure 3C), such as
the peak protein level ( 85A.U. at hours 2, 5 and 8), the
period that the ﬂuorescent protein is present ( 2h),
the rate of protein production and the precipitous degra-
dation as cells go through the G1/S transition (Figure 3C).
Additionally, the peaks centered around hours 2, 5 and
8 lack a plateau, indicating that the system never reaches a
steady-state before the protein is degraded.
The daughter arrester enriches the population
for oldest cells
During exponential phase, a wild-type culture of budding
yeast will roughly contain 50% new daughter cells, 25%
cells that have divided once, 12.5% that have budded
twice, etc., so that the oldest n-generational cells should
be 100/2
n% of the population. While the population dis-
tribution of the daughter arrester strain should be
unchanged relative to the wild-type strain in absence of
drug, it should be signiﬁcantly altered in the presence
of the drug since newly budded daughters do not divide.
To explore to what degree our device can enrich for this
oldest population of cells, we identiﬁed mother–daughter
lineages present at the beginning of the microﬂuidic
imaging experiment in either the presence or absence of
drug, mapped the number of divisions undergone by these
cells and the descendents, and calculated the percentage of
the population corresponding to the oldest mother cell.
Using the mother–daughter lineage shown in Figure 3A
and B, we calculated and plotted in the percentage of the
population corresponding to the oldest mother cell as a
function of time for representative trajectories. In the
absence of drug (Figure 4A, red line), the percentage of
oldest cells drops sharply as would be expected. However,
in the presence of drug (green line), the fraction of oldest
cells is much higher, reﬂecting the much greater number
of oldest cells in the total population. This trend
is reproduced over many manually tracked mother–
daughter lineages (n=15 mother cells), conﬁrming that
the daughter arrester strain can be used to create popula-
tions enriched in old cells.
Mapping cellular divisions also reveals that the repli-
cative age distribution of the daughter arrester strain
(Figure 4B, analysis of Figure 3A and B) is radically
altered in the presence of drug (red) relative to without
drug (green). In the absence of drug, the population dis-
tribution of the daughter arrester strain closely resembles
the expected wild-type distribution. In the presence of
drug (Figure 4B, red), the age distribution is bimodal.
While most of the cells in the population are arrested
daughter cells, the mother cells that budded four times
are highly enriched (20%) compared with the population
in the absence of drug (4%). Again, these results were
qualitatively reproduced over several mother–daughter
lineages (n=15 mother cells), and we never observed a
mother cell arrest or die. Thus growing the daughter
arrester strain in the presence of drug radically changes
the population replicative age distribution, creating one
peak population of newly born daughter cells and a
second peak corresponding to cells with n number of cell
divisions. The number of cell divisions—n—can be
2732 Nucleic Acids Research, 2010,Vol.38, No. 8manipulated by growing the cells for longer times, e.g.
diﬀerent stages of the time course in Figure 3B.
DISCUSSION AND CONCLUSIONS
Here we have designed and implemented a genetically
encoded biological device—the daughter arrester—that
can incorporate information from an external stimulus
and from the endogenous cell cycle. In the presence of a
drug, the daughter arrester strain shows reduced, linear
growth on the population level. Furthermore, time-lapse
ﬂuorescence microscopy shows that the device reduces the
overall growth rate by arresting daughter cells if and only
if drug is present. The arrest of daughter cells leads to an
enrichment of older mother cells in the population and a
time-dependent shift in the replicative age distribution
within a population.
Close examination of our device function in the absence
of drug reveals new details on the timing and speciﬁcity of
cell-cycle regulatory elements. We observed very weak, but
measurable, expression of the conditional killer protein in
mother cells, which we attribute to slight expression from
the DSE4 promoter in mother cells. This weak expression
most likely arises from imperfect segregation of the
transcriptional activator Ace2 or imperfect regulation by
the kinase Cbk1 (32,33). In daughters, the conditional
killer protein expressed by the DSE4 promoter does not
reach a steady-state concentration, indicating that the
DSE4 promoter is still active when the G1/S degradation
tag triggers degradation of the protein. This information
on the relative timing of cell-cycle events in S. cerevisiae is
an example of new biology that can be learned from
building synthetic devices. The rates of protein production
and degradation, and the peak protein concentration
(Figure 3C) appear remarkably consistent across single
cells. However, a rigorous analysis of this behavior is
outside the scope of the paper. We speculate that this
apparent lower variability is due to the higher regulation
of cell-cycle elements and that with more regular behavior,
cell cycle modules may have special utility in synthetic
biology.
This genetic device also reveals additional information
on the action of URA3 and 5-FU. This device provides a
ﬁrst example that even transiently expressed Ura3p can
convert suﬃcient 5-FOA into 5-FU to cause cell arrest.
However, the increased ability of the DSE4-based early
daughter arrester to restrict growth relative to the CTS1
late daughter arrester may suggest that the longer resi-
dence time of the conditional killer protein translates
into a higher toxic eﬀect on cells’ transcriptional and
translational mechanism. That the conditional killer
protein induces arrest after it has been degraded is also
somewhat unexpected. In particular, despite 5-FU
toxic-eﬀects on both DNA and RNA processing, it is
striking that the cells still past the G1/S checkpoint and
enter S-phase, as conﬁrmed by the appearance of a small
bud. The cell-cycle program progresses until cells eventu-
ally arrest and do not ﬁnish the cell cycle. We speculate
that the cells are arresting in S/G2 or G2/M, where genome
duplication becomes critical to go through the checkpoint.
While our device does indeed arrest growth of daughter
cells, it would be desirable to reduce expression of the
killer protein in mother cells and simultaneously increase
expression of the killer protein in daughter cells. The most
straightforward way to achieve this goal would be to make
the daughter-speciﬁc promoter less leaky in mother cells
and a stronger promoter in daughter cells. Since there are
several putative daughter-speciﬁc promoters in addition to
DSE4 and CTS1, creating variants of our device with
these alternative promoters might allow us to identify an
even more selective device. Alternatively, future experi-
mental approaches might entail using directed evolution
coupled with ﬂow cytometry analysis to generate and
select artiﬁcial promoter variants that have higher expres-
sion in daughters and simultaneously lower expression in
mothers.
Successful design and construction of this new genetic
device expands the limits of modularity used in synthetic
biology. Speciﬁcally, we show for the ﬁrst time that
cell-cycle speciﬁc promoters and degradation sequences
can be used as modular timing elements in genetic
devices. Importantly, they also accomplish these functions
without signiﬁcantly aﬀecting the overall cell-cycle pro-
gression, suggesting that they do not overload the
endogenous cell cycle machinery. We also show that
these timing devices can be used with exogenous signals,
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Figure 4. The daughter arrester strain can enrich a yeast cell popula-
tion in older cells. (A) Starting populations of two cells—one mother
and daughter—were tracked over time and the percentage of original
mother cells (highest replicative age) in the total population was
calculated. In the absence of drug (red), the percentage sharply drops
over time, while in the presence of drug (green) it decreases signiﬁcantly
less over time. (B) The replicative age distribution after 8h of cell
growth in the absence (green) and presence of drug (red) shows that
the age distribution is radically skewed in the presence of drug.
Nucleic Acids Research,2010, Vol.38, No. 8 2733i.e. a drug, to give ﬁne control over device activity.
We anticipate that the daughter arrester and related
variants will have uses in basic research and biotechnology
applications. For example, the daughter speciﬁc arrester
can be used to study aging in multiple ways. Since the
daughter arrester allows mother cells to be tracked by
microscopy over many more generations than its parent
strain, it will permit examination of the time-evolution of
age-related changes to thus elucidate mechanisms under-
lying aging. Additionally, cell populations enriched in
mother cells that have undergone many divisions can be
generated in much smaller cell cultures than the current
state of the art methods, eliminating a key bottleneck to
proteomic analysis of old cells. These novel tools would
enable simpliﬁed and closer analysis of replicative aging
processes. In biotechnology applications, variations of this
device could be used as a fail-safe device to prevent cells
from proliferating under certain conditions.
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